The Swedish MS registry - clinical support tool and scientific resource

Acta Neurologica Scandinavica

Volumn 132, Issue S199, 2015, Pages 11-19

  Hillert, J ^a,b   Stawiarz, L ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Clinical research; Disease modifying drugs; EDSS; Electronic medical record; Graphical medical records; MRI; MS registry; Multiple sclerosis; Multiple sclerosis epidemiology; Multiple sclerosis genetics; Multiple sclerosis immunology; National registry; Outcome measures; PROMs

Indexed keywords

DRUG ANTIBODY;

CLINICAL DECISION MAKING; CONSENSUS DEVELOPMENT; ENVIRONMENT; HUMAN; MULTIPLE SCLEROSIS; PATIENT INFORMATION; PATIENT PARTICIPATION; REGISTER; REVIEW; SWEDEN; HISTORY; INCIDENCE; PREVALENCE; RESEARCH;

HISTORY, 20TH CENTURY; HUMANS; INCIDENCE; MULTIPLE SCLEROSIS; PREVALENCE; REGISTRIES; RESEARCH; SWEDEN;

EID: 84930406915     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12425     Document Type: Review

References (29)

1. Andersen O. From the Gothenburg cohort to the Swedish multiple sclerosis registry. Acta Neurol Scand 2012;195:13-9.
2. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993;116(Pt 1):117-34.
3. Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Thompson AJ. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry 2002;73:701-4.
4. Johnsen LG, Hellum C, Nygaard OP et al. Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc disease. BMC Musculoskelet Disord 2013;14:148.
5. Stawiarz L, Hagel E, Eriksson H, Hillert J, Swedish MS Registry. A visualization and analysis platform in the Swedish national MS registry for real-time data feedback. Mult Scler 2014;20(Suppl 1):163-4.
6. Tedeholm H, Lycke J, Skoog B et al. Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs. Mult Scler 2013;19:765-74.
7. Westerlind H, Ramanujam R, Uvehag D et al. Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden. Brain 2014;137:770-8.
8. International Multiple Sclerosis Genetics C, Wellcome Trust Case Control C, Sawcer S et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214-9.
9. International Multiple Sclerosis Genetics C, Beecham AH, Patsopoulos NA et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013;45:1353-60.
10. Piehl F, Holmen C, Hillert J, Olsson T. Swedish natalizumab (Tysabri) multiple sclerosis surveillance study. Neurol Sci 2011;31(Suppl. 3):289-93.
11. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009;73:696-701.
12. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L. Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Mult Scler 2011;17:788-93.
13. Baarnhielm M, Hedstrom AK, Kockum I et al. Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. Eur J Neurol 2012;19:955-62.
14. Hedstrom AK, Hillert J, Olsson T, Alfredsson L. Nicotine might have a protective effect in the etiology of multiple sclerosis. Mult Scler 2013;19:1009-13.
15. Sundqvist E, Sundstrom P, Linden M et al. Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun 2012;13:14-20.
16. Hedstrom A, Alfredsson L, Lundkvist Ryner M, Fogdell-Hahn A, Hillert J, Olsson T. Smokers run increased risk of developing anti-natalizumab antibodies. Mult Scler 2013;20:1081-5.
17. Hedstrom AK, Hillert J, Olsson T, Alfredsson L. Smoking and multiple sclerosis susceptibility. Eur J Epidemiol 2013;28:867-74.
18. Hedstrom AK, Hillert J, Olsson T, Alfredsson L. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurol 2014;71:300-5.
19. Hedstrom AK, Hillert J, Olsson T, Alfredsson L. Reverse causality behind the association between reproductive history and MS. Mult Scler 2014;20:406-11.
20. Baarnhielm M, Olsson T, Alfredsson L. Fatty fish intake is associated with decreased occurrence of multiple sclerosis. Mult Scler 2014;20:726-32.
21. Hedstrom AK, Sundqvist E, Baarnhielm M et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain 2011;134:653-64.
22. Link J, Lundkvist Ryner M, Fink K et al. Human leukocyte antigen genes and interferon beta preparations influence risk of developing neutralizing anti-drug antibodies in multiple sclerosis. PLoS ONE 2014;9:e90479.
23. Hedstrom AK, Ryner M, Fink K et al. Smoking and risk of treatment-induced neutralizing antibodies to interferon beta-1a. Mult Scler 2014;20:445-50.
24. Imrell K, Landtblom AM, Hillert J, Masterman T. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 2006;67:1062-4.
25. Mero IL, Gustavsen MW, Saether HS et al. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. PLoS ONE 2013;8:e58352.
26. Gustavsen MW, Viken MK, Celius EG et al. Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general. J Neuroimmunol 2014;274:174-9.
27. Karrenbauer VD, Prejs R, Masterman T, Hillert J, Glaser A, Imrell K. Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients. J Neuroimmunol 2013;254:170-3.
28. Ferreira D, Voevodskaya O, Imrell K et al. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy. J Neuroimmunol 2014;274:149-54.
29. Ahlgren C, Oden A, Lycke J. High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler 2011;17:901-8.